Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sumatriptan prophylaxis for postelectroconvulsive therapy headaches

C DeBattista1, K Mueller

  • 1Department of Psychiatry and Behavioral Sciences, Stanford (Calif) University School of Medicine 94305, USA.

Headache
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinal nerve fibre layer thickness reflects characteristics of brain grey and white matter.

bioRxiv : the preprint server for biology·2025
Same author

Investigating Sources of Variability and Error in Simulations of Carbon Dioxide in an Urban Region.

Atmospheric environment (Oxford, England : 1994)·2024
Same author

Anti-HEV seroprevalence and rate of viremia in a German cohort of dogs, cats, and horses.

Scientific reports·2023
Same author

Interrater Reliability in the Measurement of Flow Characteristics on Color-Coded Quantitative DSA of Brain AVMs.

AJNR. American journal of neuroradiology·2020
Same author

Case report of a cervical myelomalacia caused by a thoracolumbar intradural disc herniation leading to intracranial hypotension.

Journal of neurology·2020
Same author

Serum BDNF levels correlate with regional cortical thickness in minor depression: a pilot study.

Scientific reports·2020
Same journal

Hypothalamus as a conductor of the migraine prodrome: A narrative review.

Headache·2026
Same journal

Pain reduction and tolerability of mirogabalin in trigeminal neuralgia: A prospective observational study.

Headache·2026
Same journal

Risk of hypertension after CGRP antagonist treatment in migraine: A systematic review and meta-analysis.

Headache·2026
Same journal

Sexual dysfunction is underrecognized in patients with migraine: A systematic review and meta-analysis.

Headache·2026
Same journal

College students' migraine perceptions and lived experiences: A qualitative study.

Headache·2026
Same journal

A patient-centered conceptual model and measurement framework for migraine experience developed by the Migraine Clinical Outcome Assessment System.

Headache·2026
See all related articles

Headaches after electroconvulsive therapy (ECT) affect many patients, with some experiencing persistent or severe symptoms. This case report highlights sumatriptan as a potential prophylactic treatment for refractory post-ECT headaches.

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Headaches are a common side effect of electroconvulsive therapy (ECT), with an estimated incidence of 26%.
  • Some patients with a history of migraines experience similar headaches after ECT, while others report improvement in pre-existing headache conditions.
  • The exact mechanisms behind ECT-induced headaches are not fully understood, though serotonergic pathways are implicated.

Observation:

  • A case of severe, refractory headaches following electroconvulsive therapy (ECT) is presented.
  • The patient experienced persistent headaches that did not respond to standard treatments.
  • This highlights a significant unmet need in managing post-ECT headache complications.

Findings:

  • Prophylactic treatment with sumatriptan was initiated for the severe, refractory post-ECT headaches.

Related Experiment Videos

  • The sumatriptan treatment demonstrated a positive response in managing the patient's headaches.
  • This suggests sumatriptan may be an effective therapeutic option for specific cases.

    • Implications:

    • This case report suggests sumatriptan as a potential prophylactic strategy for severe, refractory post-ECT headaches.
    • Further research is warranted to confirm the efficacy and safety of sumatriptan in larger patient cohorts.
    • Understanding and managing post-ECT headaches can improve patient tolerance and outcomes of ECT treatments.